Thyroid and androgen receptor signaling are antagonized by μ‐Crystallin in prostate cancer
Authors:
Open Access
- 9 October 2020
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 148 (3) , 731-747
Abstract
Androgen deprivation therapy (ADT) remains a key approach in the treatment of prostate cancer (PCa). However, PCa inevitably relapses and becomes ADT resistant. Besides androgens, there is evidence that thyroid hormone thyroxine (T4) and its active form 3,5,3′‐triiodo‐L‐thyronine (T3) are involved in the progression of PCa. Epidemiologic evidences show a higher incidence of PCa in men with elevated thyroid hormone levels. The thyroid hormone binding protein μ‐Crystallin (CRYM) mediates intracellular thyroid hormone action by sequestering T3 and blocks its binding to cognate receptors (TRα/TRβ) in target tissues. We show in our study that low CRYM expression levels in PCa patients are associated with early biochemical recurrence and poor prognosis. Moreover, we found a disease stage‐specific expression of CRYM in PCa. CRYM counteracted thyroid and androgen signaling and blocked intracellular choline uptake. CRYM inversely correlated with [18F]fluoromethylcholine (FMC) levels in positron emission tomography/magnetic resonance imaging of PCa patients. Our data suggest CRYM as a novel antagonist of T3‐ and androgen‐mediated signaling in PCa. The role of CRYM could therefore be an essential control mechanism for the prevention of aggressive PCa growth.Keywords
All Related Versions
Funding Information
- Ministerstvo Školství, Mládeže a Tělovýchovy (LQ1601, LM22018132)
- University of Nottingham
- Austrian Science Fund (SFB‐F06105, SFB‐ F04707, P26011, P23579‐B)
This publication has 38 references indexed in Scilit:
- The Pro Allele of the p53 Codon 72 Polymorphism Is Associated with Decreased Intratumoral Expression of BAX and p21, and Increased Breast Cancer RiskPLOS ONE, 2012
- Changes in the metabolic profile of rat liver after α‐tocopherol deficiency as revealed by metabolomics analysisNMR in Biomedicine, 2010
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptorProceedings of the National Academy of Sciences, 2010
- Study of the transport of thyroid hormone by transporters of the SLC10 familyMolecular and Cellular Endocrinology, 2010
- Identification of µ‐crystallin as an androgen‐regulated gene in human prostate cancerThe Prostate, 2009
- Spiking Expression of μ-Crystallin mRNA during Treatment with Methimazole in Patients with Graves’ HyperthyroidismHormone and Metabolic Research, 2009
- Quantification of choline‐ and ethanolamine‐containing metabolites in human prostate tissues using 1H HR‐MAS total correlation spectroscopyMagnetic Resonance in Medicine, 2008
- Rapid nongenomic actions of thyroid hormoneProceedings of the National Academy of Sciences, 2006
- Thyroid hormone and breast carcinomaCancer, 2005
- Molecular Mechanisms of Prostate CancerEuropean Urology, 2004